Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
—
—
—
—
—
—
5 Years
Score—
Net Growth—
Net Trend—
Net Income Consistency—
Rev Growth—
Rev Trend—
Revenue Consistency—
Bolt Biotherapeutics fundamental performance
Across Bolt Biotherapeutics's full reported history, from 2021 to 2025, revenue grew from $ 1M to $ 7M and net income went from -$ 98M to -$ 33M. Revenue increased in 75% of the years measured; net income in 100%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 3.45 | — |
1 Year2025-08-12 | $ 5.50 | -37.27% |
5 Years2021-08-12 | $ 246.20 | -98.60% |
All Time2021-02-05 | $ 643.00 | -99.46% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-02-05 |
|---|---|---|---|---|
| Price | $ 3.45 | $ 5.50 | $ 246.20 | $ 643.00 |
| Return | — | -37.27% | -98.60% | -99.46% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 7M | -$ 33M | $ 27M |
| 2024 | $ 7M | -$ 63M | $ 47M |
| 2023 | $ 7M | -$ 69M | $ 102M |
| 2022 | $ 5M | -$ 88M | $ 168M |
| IPO2021 | $ 1M | -$ 98M | $ 186M |
Explore beyond BOLT
You're looking at Bolt Biotherapeutics. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
